Show simple item record

dc.contributor.authorShaw, Bernadette
dc.contributor.authorPeters, Michael
dc.contributor.authorLogan, Deirdre G.
dc.contributor.authorSheidow, Ashli
dc.contributor.authorDavis, Maryann
dc.date2022-08-11T08:10:17.000
dc.date.accessioned2022-08-23T17:02:37Z
dc.date.available2022-08-23T17:02:37Z
dc.date.issued2018-02-01
dc.date.submitted2018-02-15
dc.identifier.doi10.7191/pib.1122
dc.identifier.urihttp://hdl.handle.net/20.500.14038/44249
dc.description.abstractDrs. Maryann Davis of the Transitions to Adulthood Center for Research at the University of Massachusetts Medical School and Ashli Sheidow and Michael McCart of the Oregon Social Learning have previously demonstrated that Multisystemic Therapy for Emerging Adults (MST-EA) is an intervention that successfully engages and retains young adults with serious mental health conditions in treatment. This Research in the Works is about a new trial awarded by NIMH called Effectiveness Trial of Treatment to Reduce Serious Antisocial Behavior in Emerging Adults with Mental Illness. This study builds on Drs. Davis and Sheidow’s previous work and is a randomized controlled trial comparing outcomes of 240 participants assigned to either the MST-EA intervention or enhanced treatment as usual. This study will determine if MST-EA is a more effective treatment than the enhanced usual treatment for this population. Currently, there is no intervention with proven efficacy to reduce criminal behavior for emerging adults with serious mental health conditions and this study is an important step in developing one.
dc.language.isoen_US
dc.rightsCopyright © University of Massachusetts Medical School.
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/3.0/
dc.subjectEmployment
dc.subjectLegal Issues
dc.subjectTransition Age Youth
dc.subjecttransition age youth
dc.subjectTAY
dc.subjecttransition-age youth
dc.subjectresearch
dc.subjectemerging adults
dc.subjectMultisystemic Therapy
dc.subjectMST. MST-EA
dc.subjectMultisystemic Therapy for Emerging Adults
dc.subjectreduce criminal behavior
dc.subjectintervention
dc.subjectrandomized controlled trial
dc.subjectmental health
dc.subjectserious mental health condition
dc.subjectyoung adult
dc.titleTesting Whether Multisystemic Therapy for Emerging Adults Can Reduce Their Justice System Involvement
dc.typeResearch in the Works
dc.identifier.legacyfulltexthttps://escholarship.umassmed.edu/cgi/viewcontent.cgi?article=1122&context=pib&unstamped=1
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/pib/vol15/iss2/1
dc.legacy.embargo2018-02-15T00:00:00-08:00
dc.identifier.contextkey11567331
refterms.dateFOA2022-08-23T17:02:37Z
html.description.abstract<p>Drs. Maryann Davis of the Transitions to Adulthood Center for Research at the University of Massachusetts Medical School and Ashli Sheidow and Michael McCart of the Oregon Social Learning have previously demonstrated that Multisystemic Therapy for Emerging Adults (MST-EA) is an intervention that successfully engages and retains young adults with serious mental health conditions in treatment. This <em>Research in the Works</em> is about a new trial awarded by NIMH called <strong>Effectiveness Trial of Treatment to Reduce Serious Antisocial Behavior in Emerging Adults with Mental Illness</strong>. This study builds on Drs. Davis and Sheidow’s previous work and is a randomized controlled trial comparing outcomes of 240 participants assigned to either the MST-EA intervention or enhanced treatment as usual. This study will determine if MST-EA is a more effective treatment than the enhanced usual treatment for this population. Currently, there is no intervention with proven efficacy to reduce criminal behavior for emerging adults with serious mental health conditions and this study is an important step in developing one.</p>
dc.identifier.submissionpathpib/vol15/iss2/1


Files in this item

Thumbnail
Name:
MST_RITW_FINAL_3.8.18.pdf
Size:
619.1Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record

Copyright © University of Massachusetts Medical School.
Except where otherwise noted, this item's license is described as Copyright © University of Massachusetts Medical School.